<DOC>
	<DOCNO>NCT01701830</DOCNO>
	<brief_summary>The aim study evaluate whether low level serum omentin-1 associate carotid atherosclerosis mediate inflammation .</brief_summary>
	<brief_title>Serum Omentin-1 Carotid Atherosclerosis In Non-Diabetic Chronic Kidney Disease</brief_title>
	<detailed_description>Atherosclerotic cardiovascular disease markedly increase chronic kidney disease . There lot risk factor , along conventional risk factor . Serum onemtin-1 adipokine suggest new marker vascular disease.It anti-atherogenic property . Studies investigate serum omentin-1 level usually conduct patient diabetes mellitus .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Artery Diseases</mesh_term>
	<criteria>age 18 65 year old chronic kidney disease stage 34 Chronic kidney disease stage 5 The history ischemic cardiovascular disease ( myocardial infarction , unstable angina , stroke , peripheral artery disease , cardiovascular revascularization ) Severe heart failure Stage 2 hypertension Diabetes mellitus Corticosteroid therapy Severe hepatic disease Smoking Inflammatory disease Acute infectious disease Malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>omentin-1</keyword>
	<keyword>carotid atherosclerosis</keyword>
	<keyword>kidney disease</keyword>
</DOC>